Vectura poaches Immunocore CFO Paul Fry

London-listed pharmaceuticals business Vectura Group said it had appointed Paul Fry from Immunocore to take over as chief financial officer from Andrew Derodra.

Fry will begin his work with Vectura on 29 October, the company said in a statement.

Derodra leaves the group and its board on 31 July, but Vectura noted that interim arrangements from within the group were in place ahead of Fry joining the company.

Before joining Immunocore, Fry served as director of global finance operations at Vodafone, where he was responsible for key financial controller activities and core processes as well as large transformation programmes.

James Ward-Lilley, Vectura's chief executive, said: "Paul's appointment reinforces our commitment to attracting talent with relevant sector and operational experience that will help us deliver our strategy. Together with the rest of the board and the wider executive team, I am very much looking forward to working with Paul."

At 1240 BST, Vectura shares had picked up 2.12% to 79.65p.